All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...